Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Therapeutic Discovery

Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters

KyoungHyun Kim, Gayathri Chadalapaka, Satya S. Pathi, Un-Ho Jin, Ju-Seog Lee, Yun-Yong Park, Sung-Gook Cho, Sudhakar Chintharlapalli and Stephen Safe
KyoungHyun Kim
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gayathri Chadalapaka
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satya S. Pathi
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Un-Ho Jin
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ju-Seog Lee
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yun-Yong Park
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sung-Gook Cho
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudhakar Chintharlapalli
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Safe
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-12-0181 Published September 2012
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: June 2012 to January 2021

AbstractFull-text HTMLPDF
Total322413101175

Cited By

Article Information

Volume 11, Issue 9, pp. 1852-1862

DOI 
https://doi.org/10.1158/1535-7163.MCT-12-0181
PubMed 
22752225

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received February 17, 2012
  • Revision received May 18, 2012
  • Accepted May 28, 2012
  • Published first June 29, 2012.

Article Versions

  • Previous version (June 29, 2012 - 13:02).
  • Previous version (August 28, 2012 - 12:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2012 American Association for Cancer Research.

Author Information

  1. KyoungHyun Kim1,
  2. Gayathri Chadalapaka3,
  3. Satya S. Pathi3,
  4. Un-Ho Jin1,
  5. Ju-Seog Lee2,
  6. Yun-Yong Park2,
  7. Sung-Gook Cho2,
  8. Sudhakar Chintharlapalli4, and
  9. Stephen Safe1,3
  1. Authors' Affiliations: 1Institute of Biosciences and Technology, Texas A&M Health Science Center; 2Department of Systems Biology, M.D. Anderson Cancer Center, The University of Texas, Houston; 3Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; and 4Eli Lilly and Company, Lilly Research Labs - Oncology Division, Indianapolis, Indiana
  1. Corresponding Author:
    Stephen Safe, Department of Veterinary Physiology and Pharmacology, Texas A&M University, 4466 TAMU, Vet. Res. Bldg. 410, College Station, TX 77843. Phone: 979-845-5988; Fax: 979-862-4929; E-mail: ssafe{at}cvm.tamu.edu
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 11 (9)
September 2012
Volume 11, Issue 9
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
KyoungHyun Kim, Gayathri Chadalapaka, Satya S. Pathi, Un-Ho Jin, Ju-Seog Lee, Yun-Yong Park, Sung-Gook Cho, Sudhakar Chintharlapalli and Stephen Safe
Mol Cancer Ther September 1 2012 (11) (9) 1852-1862; DOI: 10.1158/1535-7163.MCT-12-0181

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
KyoungHyun Kim, Gayathri Chadalapaka, Satya S. Pathi, Un-Ho Jin, Ju-Seog Lee, Yun-Yong Park, Sung-Gook Cho, Sudhakar Chintharlapalli and Stephen Safe
Mol Cancer Ther September 1 2012 (11) (9) 1852-1862; DOI: 10.1158/1535-7163.MCT-12-0181
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Sorafenib Targets VCP in Hepatocellular Cancer Cells
  • RSK2 as Therapeutic Target for Myeloma
  • Dll4-Fc Suppresses Liver Metastasis of SCLC Cells
Show more Therapeutic Discovery
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement